Trials / Recruiting
RecruitingNCT05179954
Lipoprotein Kinetics in T1D
Apolipoprotein C3-loading of Apolipoprotein B100 Lipoproteins and Cardiovascular Disease in Patients With Type 1 Diabetes
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to understand how type 1 diabetes (T1D) increases the risk for cardiovascular diseases (heart attack and stroke). To this end, the investigators will compare apolipoprotein and triglyceride kinetics in people wtih T1D and healthy control participants.
Detailed description
Not required
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Metabolic testing | Participants will complete a metabolic testing protocol that includes intravenous infusion of stable isotope labeled tracers and blood sampling to determine lipoprotein kinetics |
Timeline
- Start date
- 2022-05-09
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
- First posted
- 2022-01-06
- Last updated
- 2026-02-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05179954. Inclusion in this directory is not an endorsement.